(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 4.13% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.05%.
Thermo Fisher Scientific's revenue in 2024 is $42,492,000,000.On average, 8 Wall Street analysts forecast TMO's revenue for 2024 to be $16,392,245,223,091, with the lowest TMO revenue forecast at $16,333,549,849,252, and the highest TMO revenue forecast at $16,496,252,614,768. On average, 8 Wall Street analysts forecast TMO's revenue for 2025 to be $17,528,645,253,968, with the lowest TMO revenue forecast at $17,244,241,018,339, and the highest TMO revenue forecast at $17,732,631,784,965.
In 2026, TMO is forecast to generate $18,878,528,917,958 in revenue, with the lowest revenue forecast at $18,768,033,493,939 and the highest revenue forecast at $18,994,505,788,375.